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dence or ambulation, which would significantly reduce the
expected benefit from TAAA repair, have not been fac-
tored into the decision algorithm for the patient with
TAAA. In this study, we determined immediate and 1-year
survival rate and function (living situation, ambulation) in
patients who underwent TAAA repair and we attempted
to define predictors of these outcomes that could be used
to improve the selection of patients for this procedure.
MATERIAL AND METHODS
Surgical techniques. TAAA repair was performed
with standard surgical techniques, and the details of the
procedure have been previously reported.7 A thoracoab-
dominal incision and a retroperitoneal approach were used.
The diaphragm was incised circumferentially, and the
aneurysm was exposed throughout its extent. The
aneurysm was repaired with a Dacron graft tube or bifur-
cated graft as necessary, and each patient was administered
mannitol (0.5 gm/kg), methylprednisolone (15 mg/kg),
and renal-dose dopamine (5 mg/kg/h) before aortic cross
clamping. Perfusion of the visceral vessels was reestablished
with either a separate Crawford patch or a long proximal
anastomosis graft hood that encompassed the visceral
arteries as appropriate. A lumbar spinal drain was placed
before the procedure and was left in place for 48 hours
after surgery to maintain the cerebrospinal fluid pressure at
The traditional indications for treatment of thora-
coabdominal aortic aneurysms (TAAAs) represent a bal-
ance between the mortality associated with operative
repair and the long-term rupture risk. The risk of in-
hospital death associated with TAAA repair has been
reported to range from 11% to 30%.1,2 The long-term
mortality rate from aneurysm rupture in patients who do
not undergo treatment appears to be significantly higher,3
although prospective natural history data are lacking.
Unfortunately, serious nonfatal organ injury (pulmonary,
20% to 40%; renal, 20% to 30%; and spinal cord, 5% to
15%) also commonly occurs after TAAA repair.1,2,4-6 Such
insults in elderly patients with TAAA likely limit functional
recovery and long-term survival. Such loss of indepen-
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Objective: Repair of thoracoabdominal aortic aneurysms (TAAAs) is performed for the improvement of long-term sur-
vival and the preservation of function. The determination of functional outcome and the identification of predictors of
survival and functional recovery after TAAA repair are key to proper patient selection.
Methods: This retrospective review of clinical data was performed in an academic medical center. The demographics,
Crawford aneurysm type (I-18, II-33, III-22, IV-28), preoperative risk factors, operative characteristics, and postop-
erative complications and outcomes were recorded from the medical records for 101 consecutive patients who under-
went TAAA repair (58 elective and 43 urgent/emergent). Functional status and living situation at hospital discharge
and 12 months after discharge were determined from follow-up examination records or telephone contact with sur-
viving patients. The patients then were categorized into “good” (survival, home, discharge to rehabilitation center,
ambulatory) or “bad” (death, discharge to or residence in a long-term care facility, non-ambulatory) outcomes.
Results: The postoperative mortality rate was 17.8% (10% in elective cases and 28% in urgent cases), and significant post-
operative complications occurred in 77% of the cases (pulmonary complications in 41%, renal complications in 28%, and
cord injury in 12%). The mean length of stay was 22.8 + 23.6 days, and at discharge, 80% of the patients were sent to
home or rehabilitation and 20% were sent to long-term care facilities. At 1 year, 15 additional patients had died. All
but two patients who had been initially discharged to rehabilitation had returned home, but only two patients who had
been discharged to long-term care facilities had returned home and both were nonambulatory. Therefore, the survival
rate at 1 year was 67%, and only 52.4% of the patients had a “good” outcome at 1 year (survival rate was 78% and rate
of “good” outcome was 63% in patients who underwent elective TAAA repair). Independent predictors of postopera-
tive death and “bad” outcome were age more than 75 years, preoperative heart disease, duration of visceral ischemia,
use of left atrial femoral bypass graft, postoperative renal dysfunction, and number of organs failing after surgery.
Conclusion: Survival and good functional outcome after TAAA repair is significantly less common than expected and is
primarily predicted with intraopertive factors and postoperative complications. Improved operative techniques and lim-
itation of visceral ischemia reperfusion injury may improve outcome after TAAA repair. (J Vasc Surg 2002;35:640-7.)
less than 12 cm H20. Patent intercostal and lumbar arter-
ies were routinely reimplanted when encountered.
Left atrial femoral bypass was used as an adjunct to
TAAA repair at the discretion of the attending surgeon
(routinely in Crawford type I and II aneurysms after intro-
duction of the technique). In the patients who underwent
left atrial femoral bypass, the left or right common femoral
artery was exposed and the chest and abdomen were
entered as described previously. A Dacron tube graft was
attached to the common femoral artery, and the graft and
the left atrium were cannulated. The patient then under-
went left atrial femoral bypass with a BioMedicus pump
(Minneapolis, Minn) and heparin-bonded tubing
(Medtronic Cardiopulmonary, Anaheim, Calif). The prim-
ing solution for the pump consisted of lactated Ringer’s
solution, mannitol, and diluted whole blood. The flow
rate through the left femoral artery was 20 to 40
mL/kg/min, and mild hypothermia of approximately
34°C was induced. Visceral perfusion was maintained with
the placement of the distal aortic cross clamp just at the
proximal extent of the aneurysm while the proximal anas-
tomosis was completed. The aortic cross clamps then were
moved sequentially down the graft and the aorta for reim-
plantation of patent intercostals/lumbar arteries and con-
struction of the Crawford patch for visceral artery
reperfusion.
Patient sample, data sources, and data collection.
One hundred one consecutive patients who underwent
TAAA repair at Shands Hospital at the University of
Florida, Gainesville, Fla, between November 1993 and
October 1999 were retrospectively reviewed. The data
sources consisted of medical records, office records, and
telephone contact with patients or family members. A
standardized questionnaire was constructed to allow con-
sistent data collection. Complete data were available for all
the patients at the time of hospital discharge. Survival
information also was available in all the patients at 1 year
of follow-up, and functional status could be determined in
75% of the patients alive at that time point.
Information that was collected included patient demo-
graphics (age and sex), preoperative risk factors (smoking
history, history of vascular disease, and previously existing
comorbidities), and preoperative ambulatory and living
status. Aneurysm type, urgency of operation, visceral
ischemia time, duration of operation, operative blood loss
(calculated as intraoperative red cell transfusion plus auto-
transfusion return, corrected for concentration), and use of
left atrial femoral bypass were also recorded. Length of
hospital stay, postoperative complications, single-organ and
multi-organ dysfunction, survival and discharge rates, and
1-year ambulatory status and living situation also were
determined. Patient outcomes then were categorized into
“good” and “bad” outcome groups. Outcome was consid-
ered “good” at hospital discharge if the patient survived
hospitalization, was ambulatory, and was discharged to
home or a rehabilitation facility. Outcome was considered
“bad” if the patient had died during hospitalization, was
nonambulatory, or was discharged to a long-term care
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facility. Outcome was defined as “good” at 1 year if the
patient was living at home and ambulatory, and “bad” if
the patient was living in a long-term care facility or non-
ambulatory. Ambulatory status at discharge and 1 year was
classified ambulatory (ambulation with or without the
assistance of another person, a cane, or a walker) or non-
ambulatory (only able to transfer from bed to chair or bed-
bound). Living situation was categorized as independent
(living at home or in a short-term rehabilitation facility) or
dependent (residence in a long-term care facility). All the
patients were considered in the calculation of outcome at
hospital discharge, but only those whose status was known
at 1 year were included in the calculation of outcome at
that time point.
Comorbid diseases were assessed, including diabetes
mellitus, hypertension, and other vascular disease, including
cerebrovascular disease. Organ systems that were evaluated
for preoperative dysfunction included the renal, cardiac,
pulmonary, liver, and hematologic systems. Preoperative
renal insufficiency was defined as a serum creatinine level of
2.0 mg/dL or more; preoperative cardiac disease was indi-
cated with active class II to IV angina pectoris, myocardial
infarction, previous coronary revascularization, or conges-
tive heart failure; and preoperative pulmonary dysfunction
was defined as chronic obstructive pulmonary disease,
recurrent bronchitis, or severe asthma. Preoperative hepatic
dysfunction was defined as cirrhosis or abnormal liver func-
tion test results, and preoperative hematologic dysfunction
was indicated with a history of excessive bleeding or abnor-
mal coagulation study results. Postoperative cardiac compli-
cations included arrhythmias and myocardial infarction;
central nervous system complications included spinal cord
injury, spinal artery syndrome, and stroke; and renal dys-
function was defined as an increase in the serum creatinine
level of 2 mg/dL or more over baseline values.7 Post-
operative pulmonary dysfunction was defined as positive
pressure mechanical ventilation for more than 7 days, and
hepatic dysfunction was defined as a lactate dehydrogenase
level of more than 500 mg/dL and either a total serum
bilirubin level of more than 3.0 mg/dL or a serum transam-
inase level of more than 200 mg/dL.7 Postoperative hema-
tologic dysfunction was defined as a platelet count of less
than 50,000/mm3 or a white blood cell count of less than
4500/ mm3. Multiorgan dysfunction was said to exist if
two or more organ systems (excluding the central nervous
system and spinal cord injuries) meet the previously men-
tioned criteria.7
Statistical analysis. Quantitative measures are ex-
pressed as mean ± one standard deviation where appropri-
ate. Clinical outcomes were determined for all the patients
and were determined separately for those patients who
underwent elective versus urgent/emergent procedures.
Outcome data were analyzed with 2 test, Fisher exact
test, and the independent Student t test where appropri-
ate. Differences were considered significant if a 95% con-
fidence interval was achieved. Potential predictors of
outcomes were investigated with the comparison of sur-
vival versus death and “good” versus “bad” outcome
groups at hospital discharge and at 1 year of follow-up
with logistic regression.
RESULTS
The mean age of the 101 patients who underwent
TAAA repair was 66.6 ± 10 years, and 69% were male
patients. Seventy-three percent had hypertension, 69% were
smokers, 43% had heart disease, and 59% had previously
undergone a vascular reconstructive procedure. In addition,
21% had pulmonary disease, 21% had renal disease, 15% had
cerebrovascular disease, and 99% were living independently
and were ambulatory before TAAA repair. The aneurysms
that were repaired were Crawford type I in 17.8%, type II
in 32.7%, type III in 21.8%, and type IV in 27.7%. Repair
was elective in 58 patients (57.4%) and urgent or emergent
in 43 patients (42.6%) for symptomatic (n = 23) or rup-
tured (n = 20) aneurysms. Left atrial femoral bypass was
used in 39.6% of the patients, the mean visceral ischemia
time was 43.5 ± 27.7 minutes, the mean calculated blood
loss was 8168 ± 9761 mL, and the mean procedure time
was 5.8 ± 2.1 hours. The mean hospital length of stay was
22.8 ± 23.6 days. No differences were seen in preoperative
demographics, risk factors, aneurysm types, use of left atrial
femoral bypass, or mean blood loss, visceral ischemia time,
and procedure time between patients who underwent elec-
tive versus urgent/emergent procedures.
After TAAA repair, 18 patients (17.8%) died before
hospital discharge (six who had undergone elective proce-
dures [10.3%] and 12 who had undergone urgent/emer-
gent procedures [27.9%]). The mortality rate was
significantly higher in the patients who underwent
urgent/emergent procedures (Table I). Postoperative
complications occurred in 76.8% and required a return to
the operating room in 30.7%. The incidence rates of post-
operative renal, pulmonary, and hematologic dysfunction
were higher in patients who underwent urgent/emergent
procedures, but none of these differences were statistically
significant. Spinal cord injury occurred in 12.6% of the
patients. Again, the incidence rate of this complication was
similar in patients who underwent elective versus
urgent/emergent procedures. In contrast, multiorgan
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dysfunction (defined as the failure of two or more organ
systems, excluding spinal cord injury) was significantly
more common in the urgent/emergent group.
Of the 83 patients who survived, 66 (79.5%) were dis-
charged to home or to a short-term rehabilitation facility
and 17 were discharged to a long-term care facility (Table
II). No differences were seen in the percentages of surviv-
ing patients who were discharged to home/rehabilitation
rather than to a long-term care facility in the elective as
compared with the urgent/emergent groups (Tables III
and IV). Thus, a “good” outcome was achieved at the
time of hospital discharge in only 63.4% of the patients
(69.0% in the patients who underwent elective repairs and
55.8% in the patients who underwent urgent/emergent
repairs). Fifteen patients died after hospital discharge dur-
ing the 1st year of follow-up (six who had been discharged
to home/rehabilitation and nine who had been discharged
to a long-term care facility). Seventeen patients (25% of
survivors) were lost to follow-up after hospital discharge
(18.4% of those discharged to home/rehabilitation and
27.8% of those discharged to a long-term care facility). All
the surviving patients with follow-up at 1 year who had
been discharged to home remained there, and all but two
patients who were discharged to a rehabilitation facility
had returned home. In contrast, only two surviving
patients with follow-up who were discharged to a long-
term care facility had returned home by 1 year and both
were nonambulatory. The two remaining patients who
were initially discharged to a rehabilitation facility and
who were alive with follow-up at 1 year had been trans-
ferred to a long-term care facility. Therefore, the survival
rate at 1 year for patients who underwent TAAA repair was
67.3% (77.6% in the patients who underwent elective
repair and 53.5% in the patients who underwent
urgent/emergent repair). Furthermore, a “good” out-
come at 1 year was achieved in only 52.4% of the patients
who underwent TAAA repair (63.3% of those who under-
went elective procedures and 37.1% of those who under-
went urgent/emergent procedures).
No preoperative predictors of in-hospital mortality or
“bad” outcome at hospital discharge were consistently
Table I. Mortality and organ failure rates after thoracoabdominal aortic aneurysm repair
Elective Urgent/emergent
All patients patients patients
(n = 101) (n = 58) (n = 43)
Mortality 17.8% 10.3% 27.9%*
Any postoperative complication 76.8% 77.6% 75.6%
Postoperative renal dysfunction 27.8% 24.1% 33.3%
Postoperative pulmonary dysfunction 41.4% 37.9% 46.3%
Postoperative hematologic dysfunction 36.7% 31.0% 45.0% 
Postoperative liver dysfunction 21.1% 22.2% 20.0%
Postoperative cardiac complication 4.0% 3.4% 4.9%
Spinal cord injury 12.1% 10.3% 14.6%
Multiple organ dysfunction 39.2% 31.0% 51.3%*
*.01 < P value < .05, for patients who underwent elective versus urgent/emergent procedures.
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Table II. Mortality rate and outcome in all 101 patients who underwent thoracoabdominal aortic aneurysm repair
At hospital discharge 
Mortality/morbidity
Postoperative death 18 (17.8%)
Spinal cord injury 12 (11.9%; 4 postoperative deaths)
Functional outcome in 83 surviving patients
Home/rehabilitation 66 (79.5%)
Ambulatory 64 (
Nonambulatory 2 (2 SCI)
Long-term care facility 17 (20.5%)
Ambulatory 0 (
Nonambulatory 17 (6 SCI)
Categorized results in all 101 patients
“Good” outcome 63.4% (64 of 101)
“Bad” outcome 36.6% (37 of 101)
1 Year after TAAA repair
Survival/death in all 101 patients
Alive 68 (67.3%)
Died during follow-up 15 (1 SCI)
Functional outcome in 51 surviving patients with follow-up
Home 46 (90.2%)
Ambulatory 44 (2 SCI)
Nonambulatory 2 (2 SCI)
Long-term care facility 5 (9.8%)
Ambulatory 0 (
Nonambulatory 5 (1 SCI)
Categorized results in 84 patients whose outcome was known (51 alive with follow-up,
18 died after surgery, and 15 died during follow-up)
“Good” outcome 52.4% (44 of 84)
“Bad” outcome 47.6% (40 of 84)
SCI, Spinal cord injury; TAAA, thoracoabdominal aortic aneurysm.
Table III. Outcome in 58 patients who underwent elective thoracoabdominal aortic aneurysm repair
At hospital discharge
Mortality/morbidity
Postoperative death 6 (10.3%)
Spinal cord injury 6 (10.3%; 2 postoperative deaths)
Functional outcome in 52 surviving patients
Home/rehabilitation 42 (80.8%)
Ambulatory 40 (
Nonambulatory 2 (2 SCI)
Long-term care facility 10 (19.2%)
Ambulatory 0 (
Nonambulatory 10 (2 SCI)
Categorized results in all 58 patients
“Good” outcome 69.0% (40 of 58)
“Bad” outcome 31.0% (18 of 58)
1 Year after TAAA repair 
Survival/death in all 58 patients
Alive 45 (77.6%)
Died during follow-up 7 (
Functional outcome in 36 surviving patients with follow-up
Home 33 (91.7%)
Ambulatory 31 (2 SCI)
Nonambulatory 2 (2 SCI)
Long-term care facility 3 (8.3%)
Ambulatory 0 (
Nonambulatory 3 (
Categorized results in 49 patients whose outcome was known (36 alive with follow-up,
6 died after surgery, 7 died during follow-up)
“Good” outcome 63.3% (31 of 49)
“Bad” outcome 36.7% (18 of 49)
SCI, Spinal cord injury; TAAA, thoracoabdominal aortic aneurysm.
identified, although the incidence rate of cerebrovascular
disease was higher in the patients who died after elective
TAAA repair (Table V). Rather, these events appeared to
be dependent primarily on the urgency of the TAAA
repair, the duration of the visceral ischemia associated with
the repair, and organ dysfunction after the repair. The inci-
dence rate of urgent/emergent TAAA repair and the dura-
tion of visceral ischemia time were significantly increased
and the use of left atrial femoral bypass graft was less com-
mon in the patients who died in the hospital or had a
“bad” outcome at hospital discharge. Postoperative com-
plications, particularly renal and pulmonary dysfunction,
spinal cord injury, and complications that required opera-
tive correction were also more common in the patients
who had both of the adverse outcomes. However, only the
duration of visceral ischemia and the number of organs
that failed after surgery were found to be independent pre-
dictors of in-hospital death or “bad” outcome at hospital
discharge with multivarient analysis results. Urgent repair,
longer visceral ischemia time, not using left atrial femoral
bypass, postoperative renal and pulmonary dysfunction,
spinal cord injury, and multiple organ dysfunction were
also associated with death or a “bad” outcome in the
patients whose outcome was known 1 year after TAAA
repair (Table VI). There was also a higher incidence rate
of age more than 75 years and of preoperative heart dis-
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ease in the patients who had these adverse events, particu-
larly when those patients who underwent elective proce-
dures were examined separately. Independent predictors
with multivariate analysis for outcome at 1 year were age
more than 75 years, preoperative heart disease, not using
left atrial femoral bypass, postoperative renal dysfunction,
and number of organs that failed after surgery, for death,
but only the number organs that failed after surgery pre-
dicted for “bad” outcome.
DISCUSSION
The overall mortality rate of 17.8% and the overall
spinal cord injury rate of 12.1% (10.3% for both in patients
who underwent elective procedures) that are reported
here are compatible with current reports of immediate
outcome after TAAA repair when survival at hospital dis-
charge rather than at 30 days is considered.8-10 In addi-
tion, the survival rate at 1 year of 67.3% (77.6% for
patients who underwent elective procedures) is similar to
the 79% 1-year survival rate reported by Crawford et al11
and the 76% 2-year survival reported by Schepens et al.12
However, despite these acceptable results for postopera-
tive mortality and spinal cord injury, only 63.4% of the
patients were ambulatory and discharged to home or to a
short-term rehabilitation facility at hospital discharge, and
only 53.6% were ambulatory and at home 1 year after
Table IV. Outcome in 43 patients who underwent urgent/emergent thoracoabdominal aortic aneurysm repair
At hospital discharge
Morbidity/mortality
Postoperative death 12 (27.9%)
Spinal cord injury 6 (14.0%; 2 postoperative deaths)
Functional outcome in 31 surviving patients
Home/rehabilitation 24 (77.4%)
Ambulatory 24 (
Nonambulatory 0 (
Long-term care facility 7 (22.6%)
Ambulatory 0 (
Nonambulatory 7 (4 SCI)
Categorized results in all 43 patients
“Good” outcome 55.8% (24 of 43)
“Bad” outcome 44.2% (19 of 43)
1 Year after TAAA repair
Survival/death in all 43 patients
Alive 23 (53.5%)
Died during follow-up 8 (1 SCI)
Functional outcome in 15 surviving patients with follow-up
Home 13 (86.7%)
Ambulatory 13 (
Nonambulatory 0 (
Long-term care facility 2 (13.3%)
Ambulatory 0 (
Nonambulatory 2 (1 SCI)
Categorized results in 35 patients whose outcome was known (15 alive with follow-up,
12 died after surgery, 8 died during follow-up)
“Good” outcome 37.1% (13 of 35)
“Bad” outcome 62.9% (22 of 35)
SCI, Spinal cord injury; TAAA, thoracoabdominal aortic aneurysm.
TAAA repair (69% and 63.3%, respectively, for patients
who underwent elective procedures, 55.8% and 37.1% for
patients who underwent urgent/emergent procedures).
Thus, in this study, one third of patients who underwent
elective TAAA repair and two thirds of patients who
underwent urgent TAAA repair did not achieve benefit
from that procedure if such benefit is defined as survival,
living at home, and being ambulatory 1 year after
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aneurysm repair. Furthermore, to achieve that benefit, the
patients spent on average 3 weeks in the hospital after
TAAA repair, and a significant number also required treat-
ment in a short-term rehabilitation facility after hospital
discharge. The great majority of patients with sympto-
matic TAAA and all of the patients with ruptured TAAA
will die without treatment, so TAAA repair in such
patients appears beneficial despite the low chance of a
Table V. Univariant predictors of in hospital mortality rate and outcome at hospital discharge after thoracoabdominal
aortic aneurysm repair
Survived Died “Good” outcome “Bad” outcome
Overall n = 83 n = 18 n = 66 n = 35
Urgent procedure 37.3% 66.7%* 36.4% 54.3% 
Visceral ischemia time (mean) 39.3 ± 17.9 min 63.9 ± 50.5 min* 36.5 ± 17.5 min 53.9 ± 38.6 min*
Use of left atrial femoral bypass 44.6% 16.7%* 43.9% 31.4%
Postoperative renal dysfunction 21.7% 64.3%* 16.7% 51.6%*
Postoperative pulmonary dysfunction 41.5% 41.2% 30.3% 63.6%*
Spinal cord injury 9.6% 25.0% 4.6% 27.3%*
Return to operating room 30.1% 33.3% 21.1% 48.6%*
Multiple organ dysfunction 32.5% 78.6%* 24.2% 71.0%*
Number of postoperative failing organs (mean) 1.3 ± 1.2 2.5 ± 1.2* 0.9 ± 1.0 2.5 ± 1.2*
Elective repair n = 52 n = 6 n = 42 n = 16
Preoperative cerebrovascular disease 11.3% 33.3%* 11.6% 18.8%
Visceral ischemia time (mean) 40.2 ± 16.4 min 84.5 ± 51.9 min* 40.1 ± 16.3 min 57.1 ± 39.6 min*
Use of left atrial femoral bypass 41.5% 16.7%* 37.2% 43.8%
Postoperative renal dysfunction 20.7% 66.7%* 18.6% 43.8%*
Postoperative pulmonary dysfunction 35.8% 66.7% 23.3% 81.3%*
Spinal cord injury 7.6% 33.3% 4.7% 25.0%*
Return to operating room 29.6% 83.3%* 20.5% 75.0%*
Multiple organ dysfunction 28.3% 66.7%* 20.9% 62.5%*
Number of postoperative failing organs (mean) 1.2 ± 1.0 2.5 ± 1.5* 0.9 ± 0.8 2.4 ± 1.1*
*.01 < P value < .05, for patients who survived versus patients who died or for “good” outcome versus “bad” outcome.
Table VI. Univariant predictors of survival rate and outcome 1 year after thoracoabdominal aortic aneurysm repair
Survived Died “Good” outcome “Bad” outcome
Overall n = 68 n = 33 n = 45 n = 39
Age > 75 years 13.2% 24.2% 13.0% 21.1%
Preoperative heart disease 34.3% 56.3%* 30.4% 52.8%
Urgent procedure 33.8% 60.6%* 28.3% 57.9%* 
Visceral ischemia time (mean) 38.5 ± 18.5 min 53.7 + 38.7 min* 34.2 ± 14.5 min 52.8 ± 36.7 min*
Use of left atrial femoral bypass 48.5% 21.2%* 43.5% 26.3%
Postoperative renal dysfunction 19.1% 48.3%* 8.7% 47.1%*
Postoperative pulmonary dysfunction 32.8% 59.4% 21.7% 63.9%*
Spinal cord injury 9.0% 16.1% 6.5% 19.4%
Return to operating room 25.0% 42.4% 21.7% 44.7%*
Multiple organ dysfunction 29.4% 62.1%* 17.4% 64.7%*
Number of postoperative failing organs (mean) 1.1 ± 1.1 2.2 + 1.3* 0.7 ± 0.8 2.3 ± 1.3*
Elective repair n = 45 n = 13 n = 31 n = 18
Age > 75 years 11.1% 38.4%* 12.1% 31.3%
Preoperative heart disease 30.6% 76.9%* 30.3% 68.8%*
Visceral ischemia time (mean) 37.3 ± 14.7 min 62.5 ± 41.9 min* 37.1 ± 14.5 min 59.1 ± 39.3 min*
Use of left atrial femoral bypass 41.7% 23.1% 36.4% 37.5%
Postoperative renal dysfunction 8.3% 53.9%* 6.1% 50.0%*
Postoperative pulmonary dysfunction 25.0% 69.2%* 18.2% 75.0%*
Spinal cord injury 11.1% 15.4% 9.1% 18.8%
Return to operating room 25.0% 76.9%* 21.2% 75.0%*
Multiple organ dysfunction 19.4% 53.9%* 15.2% 56.3%*
Number of failing organs (mean) 0.9 ± 1.0 2.1 ± 1.3* 0.8 ± 0.8 2.3 ± 1.2*
*.01 < P value < .05, for patients who survived versus patients who died or for “good” outcome versus “bad” outcome.
good outcome. In contrast, the recognition of a one in
three chance of a poor outcome at 1 year after elective
TAAA repair as compared with a risk of aneurysm rupture
and death of at most 20% per year3 makes the recommen-
dation of TAAA repair in asymptomatic patients more
problematic.
The limitations of this study include its retrospective
nature, the relatively small number of patients, and the fact
that functional outcome was not known in all the patients
at 1 year of follow-up. However, the percentage of
patients lost to follow-up was equivalent in the various
groups examined so that the better or worse outcomes in
any particular group appear to be appropriately repre-
sented in the patients whose functional outcome was
known at 1 year. Furthermore, the group of patients,
although small, had a relatively even distribution of
aneurysm types and underwent treatment in a consistent
manner with the same group of surgeons during the
period of the study. Finally, the definitions of “good” and
“bad” outcomes and ambulatory were liberal. Thus, the
functional status of some patients in the “good” outcome
group was likely worse than their preoperative status so
that outcome after TAAA repair may be even worse from
the patient’s point of view than what is reported.
The only potential preoperative predictors identified in
this study of either death or poor functional recovery with
confinement in a long-term care facility after TAAA repair
were age greater than 75 years and heart disease, and these
were not consistently identified across all the groups exam-
ined. Rather, intraoperative factors, including visceral
ischemia time, use of left atrial femoral bypass, and blood
loss and postoperative organ failure, particularly renal dys-
function, pulmonary dysfunction, and spinal cord injury
appeared to largely determine outcome. Previous study
results have shown that advanced age, female sex, preexist-
ing renal disease, preexisting chronic obstructive pulmonary
disease, preexisting cardiac disease, and repair of a Crawford
type II aneurysm increase the risk of death after TAAA
repair.6,11,13,14 Intraoperative blood loss and aortic cross-
clamp time, reoperation for bleeding, postoperative renal
and pulmonary failure, and postoperative myocardial infarc-
tion also have been reported to predict mortality after this
procedure.6,11,13,14 Previously identified risks for individual
organ failure after TAAA repair include preoperative renal
insufficiency, duration of renal ischemia, and preexisting
heart disease for postoperative renal failure, chronic obstruc-
tive pulmonary disease, smoking, and type II aneurysms for
postoperative pulmonary failure and type II aneurysm repair
(particularly aneurysms caused by aortic dissection) for
spinal cord injury.4,11,13-15 Unfortunately, few of these risk
factors for death or organ failure can be corrected before
repair of TAAA, and the exclusion of patients with these
underlying comorbid diseases has been suggested to be the
best method of lowering both organ dysfunction and mor-
tality after thoracoabdominal aneurysm repair. However, a
low incidence rate of preoperative organ dysfunction, as was
seen in this study, did not appear to be associated with an
improved outcome. In addition, Crawford and DeNatale3
JOURNAL OF VASCULAR SURGERY
646 Rectenwald et al April 2002
reported that mortality rate at 2 years in patients who were
excluded from thoracoabdominal aneurysm repair because
of comorbid diseases was 76% and that one half of these
patients died of aneurysm rupture.
The improvement of survival and functional outcome
rates after TAAA repair will depend on the limiting of sin-
gle and multiple organ dysfunction after repair. Use of left
atrial femoral bypass,16 spinal fluid drainage,17 reimplanta-
tion of patent intercostal/lumbar arteries,9 and spinal cord
cooling18 have been shown to reduce the incidence rate of
paraplegia after TAAA repair. In addition, the reduction of
visceral ischemia time and the limiting of blood loss asso-
ciated with TAAA repair appear to be methods by which
the inflammatory response associated with TAAA repair
that potentially contributes significantly to the postopera-
tive organ dysfunction can be reduced.19 Organ injury
after thoracoabdominal aortic aneurysm repair also may
potentially be reduced with anti-cytokine therapies,20
although this approach remains to be tested and previous
attempts to reduce organ injury and mortality rates asso-
ciated with sepsis with such therapies were unsuccessful.
Alternatively, endovascular stent graft repair of Crawford
type III thoracoabdominal aortic aneurysms is currently
being investigated and preliminary report results show
reduced mortality and morbidity rates associated with this
approach21 Regardless, when both postoperative survival
and functional status after TAAA repair are considered, the
results associated with TAAA repair with current surgical
techniques appear somewhat marginal, even when survival
and spinal cord injury rate results comparable with those
reported from the best series are achieved. Continued
efforts to determine the cause of complications and organ
dysfunction after TAAA repair and to identify new meth-
ods of limiting these postoperative events that limit the
benefit of TAAA repair with current surgical techniques
are essential.
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